Article

AAO honors Dr. Redmond

Michael R. Redmond, MD, has received the Outstanding Advocate Award from the American Academy of Ophthalmology (AAO). Dr. Redmond was honored for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients, and for his many contributions to AAO.

San Francisco-Michael R. Redmond, MD, has received the Outstanding Advocate Award from the American Academy of Ophthalmology (AAO). Dr. Redmond was honored for his more than 30 years of involvement with advocacy on behalf of ophthalmologists and their patients, and for his many contributions to AAO.

Dr. Redmond, who practices in a multi-specialty group practice in Pensacola, FL, has long been a driving force in the Florida Society of Ophthalmology and its political action committee. For many years, Dr. Redmond was the only ophthalmologist on the council on legislation for the Florida Medical Association, eventually becoming chairman of that council. He served on AAO’s board of trustees from 1993 to 1999, first as chairman and vice-chairman, and then as trustee-at-large. He served as AAO president in 2003.

Other positions Dr. Redmond has held with AAO include representative to the American Medical Association's house of delegates, and chairman of the long-range planning committee. In addition, he was a member of the ethics committee, the ad hoc committee for primary eye care, and the committee for state governmental affairs. He also chaired the subspecialty society relations task force and served as chairman of EyeCare America's Children's EyeCare Project.

“Dr. Redmond's legislative work, both on a national and local level, has truly had a momentous impact on the field of ophthalmology,” said David W. Parke II, MD, CEO of AAO. “I could think of no finer person to receive this award. He is a teacher, an advocate, and an ambassador for our profession.”

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.